HYQVIA
Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase · KIT · Takeda Pharmaceuticals America, Inc.
HYQVIA is a kit containing immune globulin infusion (human), 10% with recombinant human hyaluronidase. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- HYQVIA
- Generic Name
- Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase
- NDC Code (Product)
0944-2512- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125402
- Marketing Start
- 09/12/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is HYQVIA used for?
HYQVIA contains Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase. It is a kit taken as directed. Consult your doctor for specific uses.
Is HYQVIA a controlled substance?
HYQVIA is not classified as a controlled substance by the DEA.
What is the generic name for HYQVIA?
The generic name for HYQVIA is Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase. There are no other listed brand versions of Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase.
What is the NDC code for HYQVIA ?
The NDC (National Drug Code) for HYQVIA is 0944-2512, listed by Takeda Pharmaceuticals America, Inc..
Other HYQVIA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)